International Stem Cell(ISCO)
SAN DIEGO, CABiotechnology
Focus: International Stem Cell is a San Diego-based public biotech specializing in proprietary stem cell induction technology for cell therapy applications. The company operates at modest scale with $9M in FY2025 revenue and a focused pipeline across multiple therapeutic indications.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at International Stem Cell?
AI assessmentInternational Stem Cell offers stem cell technology exposure but presents significant financial and operational risk; suitable only for risk-tolerant candidates seeking early-stage optionality or those already in San Diego with low mobility needs.
Why Work Here
- Exposure to cutting-edge stem cell technology and regenerative medicine at a public company with proven regulatory pathway (Phase 3 program in conjunctival transplantation).
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$9M
Pipeline & Clinical Trials
High frequency pure tone audiometry
Hearing Loss, SensorineuralClinical Trials (1)
NCT04270916Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors
N/AHelp build intelligence for International Stem Cell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.